Clinical Trials Browser

Interventional × Glioma × avelumab × Clear all

NCT03893903 2025-03-14

AMPLIFY-NEOVAC

Phase 1 Completed

Glioma

NCT02968940 2022-06-29

Avelumab With Hypofractionated Radiation Therapy in Adults With Isocitrate Dehydrogenase (IDH) Mutant Glioblastoma

Phase 2 Completed

6 enrolled 10 charts

Parkinson Disease 4, Autosomal Dominant Lewy Body, Glioblastoma, Glioma